eNavvi and Mark Cuban Cost Plus Drug Company announce new collaboration to deliver prescription cost transparency

LOS ANGELES, May 4, 2023 /PRNewswire/ -- eNavvi, Inc., a leading provider prescription marketplace, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), an innovator in offering transparently priced medications, are thrilled to announce their new collaboration focused on...

Click to view original post